All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.

The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy


Now you can personalise
your GvHD Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more

The GvHD Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the GvHD Hub cannot guarantee the accuracy of translated content. The GvHD Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
You're logged in! Click here any time to manage your account or log out.
You're logged in! Click here any time to manage your account or log out.

Protease inhibitors

Protease inhibitors

Proteases are enzymes responsible for degradation of proteins into polypeptides or amino acids. They are involved in regulation of a variety of essential processes, including cell proliferation and differentiation, tissue homeostasis, angiogenesis, stem cell mobilization, hemostasis, blood coagulation, inflammation, immunity, and apoptosis. Agents that block activity of proteases are called protease inhibitors, and a typical example is α1-Antitrypsin (AAT), a serine protease inhibitor with anti-inflammatory, antiapoptotic, and immunomodulatory properties.

Save to your areas of interest